Home/Filings/4/A/0001437749-10-004514
4/A//SEC Filing

Anderson Mark Brian 4/A

Accession 0001437749-10-004514

CIK 0001389545other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 2:11 PM ET

Size

5.9 KB

Accession

0001437749-10-004514

Insider Transaction Report

Form 4/AAmended
Period: 2010-11-15
Transactions
  • Award

    Option (right to buy)

    2010-11-15+40,000186,000 total
    Exercise: $1.89From: 2011-11-15Exp: 2020-11-14Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]Original Form 4 filed on November 15, 2010. This amendment is filed to correct the exercise price from $1.85 to $1.885 per share.
  • [F2]Original Form 4 filed on November 15, 2010. This amendment is filed to correct the grant date from November 12, 2010 to November 15, 2010, the date the last signature to the Board Written Consent granting the options was received by the Company.

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1
  • filerCIK 0001474599

Filing Metadata

Form type
4/A
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 2:11 PM ET
Size
5.9 KB